Maxcyte, Inc. has 12 Schedule 13D or 13G filings on record since 2025-10-24. 1 holder's latest filing reports 5% or more of equity. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Capricorn Fund Managers Ltd | 7.7% | 8,200,000 | SCHEDULE 13G, 2026-02-05 | 2026-01-30 |
| Cadian Capital Management, LP | 3.5% | 3,683,052 | SCHEDULE 13G/A, 2026-02-17 | 2025-12-31 |
| BlackRock, Inc. | 1.3% | 1,402,591 | SCHEDULE 13G/A, 2026-07-29 | 2026-06-30 |
| River Global Investors Llp | 0.8% | 834,100 | SCHEDULE 13D, 2026-08-04 | 2026-07-31 |
| Mirabella Financial Services LLP | 0% | 0 | SCHEDULE 13G/A, 2026-04-10 | 2026-03-31 |
| The Vanguard Group | 0% | 0 | SCHEDULE 13G/A, 2026-03-27 | 2026-03-13 |
Purpose of Transaction (Item 4)
River Global Investors Llp
(b) An extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the issuer or any of its subsidiaries. As per the Announcement on 24 June 2026 (RNS Number: 4421J), the FCA has approved the change in control and proposed acquisition of River Global Holdings Limited. Subsequently, as of close of business on 31 July 2026, Liontrust Investment Partners (LIP) LLP assumed responsibility for the River Global Investors (RGI) LLP ICVC and ICAV funds. The relevant voting rights (approx 4.3%) attached to those holdings have therefore transferred from RGI LLP to LIP LLP. The remaining voting rights (approx 0.8%) continue to be held by RGI LLP and will be transferred at a later stage.Item 4 of the SCHEDULE 13D filed 2026-08-04
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-10-24 | River Global Investors Llp | 5.2% | SCHEDULE 13D |
| 2025-11-03 | Mirabella Financial Services LLP | 6.2% | SCHEDULE 13G |
| 2025-11-04 | Mirabella Financial Services LLP | 7.69% | SCHEDULE 13G/A |
| 2025-11-14 | Cadian Capital Management, LP | 7.7% | SCHEDULE 13G/A |
| 2026-01-21 | BlackRock, Inc. | 6.6% | SCHEDULE 13G/A |
| 2026-02-05 | Capricorn Fund Managers Ltd | 7.7% | SCHEDULE 13G |
| 2026-02-17 | Cadian Capital Management, LP | 3.5% | SCHEDULE 13G/A |
| 2026-03-27 | The Vanguard Group | 0% | SCHEDULE 13G/A |
| 2026-04-10 | Mirabella Financial Services LLP | 0% | SCHEDULE 13G/A |
| 2026-05-14 | River Global Investors Llp | 6.1% | SCHEDULE 13D |
| 2026-07-29 | BlackRock, Inc. | 1.3% | SCHEDULE 13G/A |
| 2026-08-04 | River Global Investors Llp | 0.8% | SCHEDULE 13D |
Tools for this story
Each opens in a new tab, filled in for Maxcyte, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.